Douglas R. Carlson
Vice President, Commercial Operations & Strategic
Collegium Pharmaceutical Inc
United States of America
Doug Carlson joined Collegium in March 2013 and currently serves as Vice President, Commercial Operations & Strategic Channels. In this capacity, Doug is responsible for Commercial Operations in addition to leading the Hospital and Long-term Care businesses. Doug has a multi-disciplinary background in M&A, venture capital, corporate finance, business development and operations with both large and emerging growth healthcare companies. Prior to joining Collegium, Doug was Senior Director of Business Development at BTG International Inc. where he was responsible for global specialty pharmaceutical M&A and licensing. Prior to BTG, Doug was Senior Director and Head of Business Development for Lundbeck Inc., the U.S. Headquarters of H. Lundbeck A/S. Prior to Lundbeck, Doug was Director of Corporate Development and M&A at Ovation Pharmaceuticals, Inc., where he played an integral role in the sale of Ovation to Lundbeck in 2009. Prior to Ovation, Doug was an Associate in the healthcare group at Pequot Ventures, the venture capital arm of Pequot Capital Management, Inc. Doug started his career in the healthcare investing banking group of SG Cowen & Co. He received a Bachelor of Arts degree from Trinity College in Hartford, Connecticut.
Venture capital, corporate finance, business development , management